Status:
COMPLETED
Development of a Standardized Reference Guide for Tuning Adherence to Dispense During a Initial Pharmaceutical Consulting (CP ) to the Patient With Multiple Myeloma Oral Chemotherapy Primocure
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Multiple Myeloma
Eligibility:
All Genders
18+ years
Brief Summary
The hypothesis is that the implementation of an initial Pharmaceutical Consultation (PC) program based on the provision of standardized information to patients treated for multiple myeloma as a first ...
Eligibility Criteria
Inclusion
- Inclusion criteria
- The patient must be a member or beneficiary of a health insurance plan
- The patient is at least 18 years old
- The patient is treated for multiple myeloma, is naive to any treatment and begins a chemotherapy protocol with oral therapy and whose course of care includes a stay in the Day Hospital or retrocessions.
- Criteria for non-inclusion
- The subject is participating in another study
- The subject is in an exclusion period determined by a previous study
- The subject is under the protection of justice, guardianship or curatorship
- It is impossible to give informed information about
- The patient is pregnant, parturient, or breastfeeding
- The patient receives a follow-up by a home nurse for the administration of oral medication
- The patient is treated only with oral chemotherapy in the city
- The patient has early dementia.
- Translated with www.DeepL.com/Translator
- \-
Exclusion
Key Trial Info
Start Date :
June 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2016
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04045561
Start Date
June 1 2015
End Date
December 31 2016
Last Update
August 5 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.